NDC 63539-024

Lyrica CR

Pregabalin

Lyrica CR is a Oral Tablet, Film Coated, Extended Release in the Human Prescription Drug category. It is labeled and distributed by U.s. Pharmaceuticals. The primary component is Pregabalin.

• Product ID: 63539-024_9e25a642-501e-4139-bded-aff0ded0ebf9
• NDC: 63539-024
• Product Type: Human Prescription Drug
• Proprietary Name: Lyrica CR
• Generic Name: Pregabalin
• Dosage Form: Tablet, Film Coated, Extended Release
• Route of Administration: ORAL
• Marketing Start Date: 2016-01-01
• Marketing Category: NDA / NDA
• Application Number: NDA209501
• Labeler Name: U.S. Pharmaceuticals
• Substance Name: PREGABALIN
• Active Ingredient Strength: 165 mg/1
• NDC Exclude Flag: N
• Listing Certified Through: 2019-12-31

Packaging

NDC 63539-024-02

30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (63539-024-02)

• Marketing Start Date: 2016-01-01
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 63539-024-02 [63539002402]

Lyrica CR TABLET, FILM COATED, EXTENDED RELEASE

• Marketing Category: NDA
• Application Number: NDA209501
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2016-01-01

Drug Details

Active Ingredients

Ingredient	Strength
PREGABALIN	165 mg/1

OpenFDA Data

• SPL SET ID: 847e8b4e-4c14-4c36-b824-5e1ab6a5db6f
• Manufacturer:
  • U.S. Pharmaceuticals
• UNII:
  • 55JG375S6M
• RxNorm Concept Unique ID - RxCUI:
  • 1988974
  • 1994389

NDC Crossover Matching brand name "Lyrica CR" or generic name "Pregabalin"

NDC	Brand Name	Generic Name
0071-1026	Lyrica CR	Lyrica CR
0071-1027	Lyrica CR	Lyrica CR
0071-1029	Lyrica CR	Lyrica CR
63539-024	Lyrica CR	Lyrica CR
0071-1012	Lyrica	PREGABALIN
0071-1013	Lyrica	PREGABALIN
0071-1014	Lyrica	PREGABALIN
0071-1015	Lyrica	PREGABALIN
0071-1016	Lyrica	PREGABALIN
0071-1017	Lyrica	PREGABALIN
0071-1018	Lyrica	PREGABALIN
0071-1019	Lyrica	PREGABALIN
0071-1020	Lyrica	PREGABALIN